Skip to main content
Log in

Thalidomid-Analoga, 5. Mitt.: Untersuchungen zum Metabolismus der Thalidomid-ähnlichen Verbindung K-2004

Thalidomide analogues, V. Investigations of the metabolism of the thalidomide-like compound K-2004

  • Organische Chemie und Biochemie
  • Published:
Monatshefte für Chemie / Chemical Monthly Aims and scope Submit manuscript

Abstract

The test compoundK-2004, a non-teratogenic congener of thalidomide, is quickly absorbed in the rat after oral application and, like thalidomide, degraded hydrolytically. Three metabolites appearing in the urine have been identified. The absence of teratogenicity ofK-2004 is not due to a different metabolism but probably to an altered reactivity towards a recently proposed specific receptor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Literatur

  1. 1.-3. Mitt.:H. Koch undJ. Kotlan, Mh. Chem.97, 1648 (1966);H. Koch, J. Kotlan undH. Braun, Mh. Chem.98, 702 (1967);H. Koch, J. Kotlan, E. Farkouh undM. Lindner, Mh. Chem.102, 609 (1971).

    Google Scholar 

  2. 4. Mitt.:H. Koch, J. Kotlan, E. Farkouh undG. Pischek, Ann. Chem.755, 51 (1971).

    Google Scholar 

  3. L. Stockinger undH. Koch, Arzneimittel-Forsch.19, 167 (1969).

    Google Scholar 

  4. O. Kraupp (unveröffentlicht).

  5. F. Köhler undH. Koch (in Vorbereitung).

  6. R. Beckmann, Arzneimittel-Forsch.12, 1095 (1962);13, 185 (1963).

    Google Scholar 

  7. R. Beckmann, Arch. Exper. Path. Pharmak.245, 90 (1963);J. W. Faigle, H. Keberle, W. Riess undK. Schmid, Experientia18, 389 (1962);R. D. MacKenzie undW. R. McGrath, Proc. Soc. Exptl. Biol. Med.109, 511 (1962);R. L. Smith, R. A. D. Williams undR. T. Williams, Life Sci.1, No. 7, 333 (1962);H. Schumacher, R. L. Smith undR. T. Williams, Brit. J. Pharmacol.25, 338 (1965);A. Tanaka, A. Hasegawa undG. Urakubo, Chem. Pharm. Bull. [Tokyo]13, 1263 (1965);S. Fabro, R. L. Smith undR. T. Williams, Biochem. J.104, 565, 570 (1967);S. Fabro, D. Hague undR. L. Smith, Biochem. J.103, 26P (1967);D. E. Hague, S. Fabro undR. L. Smith, J. Pharm. Pharmacol.19, 603 (1967);H. Schumacher, D. A. Blake undJ. R. Gillette, J. Pharmacol. Exptl. Therap.160, 201 (1968).

    Google Scholar 

  8. G. Pischek, E. Kaiser undH. Koch, Mikrochim. Acta [Wien]1970, 530.

  9. H. Koch, Scientia pharmac. [Wien]34, 257 (1966);H. Koch undF. Schnabel-Arikan, Scientia pharmac. [Wien]36, 121 (1968);H. Koch, Scientia pharmac. [Wien]39, 209 (1971);N. A. Jönsson, Acta Pharm. Suecica9, 521 (1972).

    Google Scholar 

  10. N. A. Jönsson, Acta Pharm. Suecica9, 543 (1972).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Mit 2 Abbildungen

Die TestsubstanzK-2004 (1 a) wie auch die Vergleichssubstanzen wurden von der Fa. F. J. Kwizda, Wien, freundlicherweise zur Verfügung gestellt.

Teil der Dissertation vonG. Pischek, Universität Wien, 1973.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pischek, G., Kaiser, E. & Koch, H. Thalidomid-Analoga, 5. Mitt.: Untersuchungen zum Metabolismus der Thalidomid-ähnlichen Verbindung K-2004. Monatshefte für Chemie 105, 74–79 (1974). https://doi.org/10.1007/BF00911290

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00911290

Navigation